Pfizer wants the FDA to let 16- and 17- year-olds get a COVID-19 booster shot
Pfizer is expected to seek authorization from the US Food and Drug Administration for its vaccine booster shot for those who are ages 16 and 17, a source familiar with the plan told CNN on Monday.
20 across the spectrum. Choose a side on the bar to jump to it.
National story. 43 articles from 20 sources. Updated Dec 1, 2021.
Left
5 sourcesPfizer wants the FDA to let 16- and 17- year-olds get a COVID-19 booster shot
Pfizer poised to request authorization for coronavirus booster for 16 and 17 year olds
Center
14 sourcesPfizer wants the FDA to let 16- and 17- year-olds get a COVID-19 booster shot
Right
1 sourceFDA moving to authorize Pfizer-BioNTech booster for 16-, 17-year-olds
The story so far
2 developments- Nov 29, 2021Pfizer expected to seek FDA authorization for boosters for those ages 16 and 17
- Nov 30, 2021Pfizer seeks US booster OK for kids aged 16-17
Who covered each development
No new developments
Quiet for 1787 daysLast development · Nov 30, 2021 — Pfizer seeks US booster OK for kids aged 16-17